Article

pressherald.com on 2021-12-21 00:27

Biogen cuts the price for its Alzheimer’s drug in half

Related news

HBiogen Cuts the Price Tag on its Alzheimer’s Drug in Half hamodia.com
Japan , Cambridge
Biogen cuts the price tag on its Alzheimer’s drug in half journalrecord.com
Japan , Cambridge
Biogen cuts Alzheimer’s drug price 50% months after approval Seattle Times
New York , Cambridge
Biogen cuts the price tag on its Alzheimer's drug in half - Mon, 20 Dec 2021 PST apnews.com
Massachusetts , Cambridge , Japan
Biogen CEO: ‘Major bottleneck’ still limits Alzheimer’s drug Seattle Times
Massachusetts , Cambridge
Biogen to replace CEO after Alzheimer’s drug flops journalrecord.com
Europe , Wall Street , Massachusetts , Cambridge
Panels find FDA, Biogen rushed Alzheimer’s drug Arkansas Online
Philadelphia , Cambridge
Biogen and Eisai revive plans for Alzheimer’s drug aducanumab, but prospects still shaky The Japan Times
Switzerland , Wall Street , Tokyo Prefecture , Japan , New York
BBiogen Earnings Were Good, but an Alzheimer’s Drug Delay Hits Shares barrons.com
Stock Island , Massachusetts
Biogen dumps dubious Alzheimer’s drug after profit-killing FDA scandal Ars Technica
Phase 4 , Switzerland , Massachusetts , Cambridge
BA Crucial FDA Hearing Looms for Biogen Alzheimer’s Drug barrons.com
Wall Street
Biogen CEO Stepping Down After Struggles With Alzheimer’s Drug Aduhelm Forbes
Cambridge
HU.S. Approval of Biogen Alzheimer’s Drug Sends Shares Soaring hamodia.com
Wall Street , Japan
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approval observer.com
BBiogen Stock Is Soaring as Hope Returns for Alzheimer’s Drug barrons.com
Wall Street , Stock Island
Biogen cutting cost of Alzheimer's drug Arkansas Online
Japan , Cambridge
Biogen plans to shut down its controversial Alzheimer’s drug Aduhelm Seattle Times
Japan